Amgen pushes back against regulators seeking to pull a key drug, while Pfizer faces investor skepticism over its obesity candidate. Meanwhile, Merck details an ambitious plan to offset the looming patent cliff of its blockbuster Keytruda and reach $70 billion in annual sales.
With its patented, FDA-recognized compound Niagen®, Niagen Bioscience (NAGE) has carved out a unique and defensible position at the intersection of nutraceuticals and pharmaceuticals. As the cellular health market expands, the company's dual-channel strategy and deep scientific validation present a compelling growth narrative for investors.
The healthcare behemoth's robust 2025 results and 2026 guidance signal a landmark year ahead, as it navigates patent expirations and pricing pressures while maintaining its coveted dividend king status.
The deep cuts at The Washington Post, blessed by owner Jeff Bezos, mark a pivotal moment. They underscore a broader trend where ultra-wealthy patrons are less saviors and more architects, fundamentally redefining news organizations to fit their vision—and their politics.
At the annual J.P. Morgan Healthcare Conference, industry leaders grappled with a transformative agenda: navigating a looming patent cliff, geopolitical shifts, and a recalibrated M&A landscape, all while betting big on AI and obesity therapeutics.
Following the elimination of over a third of its staff, Washington Post Editor-in-Chief Matt Murray publicly supports owner Jeff Bezos, framing the cuts as a necessary step for the newspaper's future viability and growth.
Major quantitative hedge funds and trading firms accumulated shares of Canopy Growth in Q3, positioning ahead of potential U.S. marijuana rescheduling. The stock's volatile reaction to recent policy news leaves the market questioning whether these 'smart money' players have held or sold their positions.
The Washington Post has laid off hundreds of employees, representing about a third of its newsroom. Among the casualties is Caroline O'Donovan, the reporter who covered Amazon—the tech giant owned by the paper's own proprietor, Jeff Bezos. The cuts signal a dramatic shift for the historic publication.
Driven by a near-doubling in sales of its key cancer drug Jemperli and sustained growth in its HIV division, GSK reported a 7% rise in annual sales. The results provide a solid foundation for new CEO Luke Miels, who is steering the company toward an accelerated pipeline strategy to navigate looming patent cliffs.
The Washington Post, owned by Jeff Bezos, has initiated sweeping layoffs affecting up to a third of its workforce, including hundreds in the newsroom. The cuts, impacting all departments, mark a profound shift for the 147-year-old institution as it grapples with steep financial losses and a declining subscriber base.
The Washington Post, owned by Jeff Bezos, is laying off approximately one-third of its newsroom staff and closing its dedicated sports and books desks as part of a strategic shift to streamline operations and refocus its journalism.
The Washington Post has initiated a major restructuring, eliminating approximately one-third of its positions across all departments, including the closure of its sports desk and a reduction in international bureaus, as the newspaper grapples with financial pressures and shifting readership.
The Washington Post initiated a major restructuring, eliminating hundreds of positions and shuttering several sections. Among those impacted was Caroline O'Donovan, a key reporter covering tech giant Amazon, signaling a significant shift in the newspaper's priorities under owner Jeff Bezos.
The newsletter platform names Mark Swierszcz as its first Canadian partnerships head, signaling a strategic bet on one of its fastest-growing markets as part of a broader global expansion drive.
Fox Corporation reported a resilient second quarter, with total revenue climbing 2% to $5.18 billion despite a tough comparison to a record political advertising period last year. The media giant highlighted robust advertising and distribution growth, record engagement for its sports and news properties, and sustained profitability for its ad-supported streaming platform, Tubi.
The Washington Post informed staff of a major organizational overhaul on Wednesday, eliminating approximately 300 roles. The cuts include the dissolution of the standalone sports desk and the closure of the books section and flagship podcast, marking one of the most significant contractions in the newspaper's recent history.
Fox Corp. CEO Lachlan Murdoch points to the network's most successful fall season launch in over a decade as evidence of a revitalized entertainment strategy, even as sports and news remain its financial bedrock.
The storied newspaper, owned by Jeff Bezos, has initiated significant layoffs impacting its sports, books, and foreign desks, amid a wider industry downturn and internal warnings about the erosion of newsroom capacity.
The maker of blockbuster drugs Wegovy and Ozempic sees its stock plunge 18% after slashing profit forecasts, citing unprecedented competition, patent expiries, and a landmark U.S. pricing deal.
The Washington Post has initiated a significant strategic reset, resulting in widespread layoffs and the closure or restructuring of several key departments, including Sports and Books, as the news organization grapples with a challenging media landscape.
